Home › Kanser ng Endometrium › Washington › Seattle
Pag-aaral pangklinika para sa Kanser ng Endometrium sa Seattle, WA
Isang pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Nagre-recruitPhase 3
- Swedish Medical Center-First Hill, Seattle
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Nagre-recruitPhase 3
- Swedish Medical Center-First Hill, Seattle
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Swedish Medical Center-First Hill, Seattle
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Nagre-recruitPhase 2
- Swedish Medical Center-First Hill, Seattle
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Nagre-recruitPhase 1/2
- Seattle Cancer Care Alliance at South Lake Union - G3630, Seattle
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Nagre-recruitPhase 2
- Swedish Medical Center First Hill, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Nagre-recruitPhase 1
- University of Washington Fred Hutchinson, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Nagre-recruitPhase 2
- Swedish Cancer Center, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Nagre-recruitPhase 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Fred Hutchinson Cancer Center, Seattle
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Nagre-recruitPhase 1/2
- Swedish Cancer Institute, Seattle
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Nagre-recruitPhase 3
- Research Site, Seattle
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Nagre-recruitPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Nagre-recruitPhase 2
- Swedish Cancer Institute, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Seattle
Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod
- Houston, TX69 pag-aaral
- New York City, NY53 pag-aaral
- Boston, MA50 pag-aaral
- Arlington, VA39 pag-aaral
- Nashville, TN37 pag-aaral
- Los Angeles, CA35 pag-aaral
- St. Louis, MO29 pag-aaral
- Philadelphia, PA29 pag-aaral
- San Antonio, TX27 pag-aaral
- Columbus, OH26 pag-aaral
- Chicago, IL26 pag-aaral
- Queens, NY26 pag-aaral
Iba pang pag-aaral sa Seattle
- Non-Small Cell Lung Cancer53 pag-aaral
- Kanser (lahat ng uri)50 pag-aaral
- Kanser sa Prostate44 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Kanser sa Suso40 pag-aaral
- Metastatic Cancer39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Kanser sa Baga33 pag-aaral
- Kanser sa Ovary31 pag-aaral
- Kanser sa Pancreas22 pag-aaral
- Multiple Myeloma22 pag-aaral
- Acute Lymphoblastic Leukemia21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.